Jpmorgan Chase & Co »

Harpoon Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5k 134 11.44
2023-09-30 $557 134 4.16

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics